Market Overview:
The global ocular drug delivery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases, rising geriatric population, and technological advancements in ocular drug delivery devices. By type, the global ocular drug delivery market is segmented into by technology and by form. The technology segment is further divided into sub-segments such as parenteral, topical, oral/enteral, and injectable. The form segment is further divided into sub-segments such as drops/liquids, gels/ointments, implants & inserts (I&I), powders & suspensions (P&S), and others (including patches). By application, the global ocular drug delivery market is segmented into hospitals & clinics; ambulatory surgical centers; homecare settings; and others (including research institutes). Geographically speaking North America dominates the global ocular drug delivery market followed by Europe owing to factors such as high prevalence of eye diseases in these regions coupled with increasing demand for better treatment options for various eye disorders among patients.
Product Definition:
Ocular drug delivery is a term used for the delivery of drugs to the eye. Ocular drug delivery can be used to treat a wide variety of conditions, including glaucoma, macular degeneration, and dry eye syndrome. The importance of ocular drug delivery lies in its ability to provide targeted treatment to the eyes while minimizing exposure to other parts of the body.
By Technology:
The global ocular drug delivery market is expected to witness significant growth over the forecast period. The factors that propel the growth of this market include increasing incidences of eye disorders such as glaucoma, cataract and diabetic retinopathy coupled with rising awareness about early diagnosis and treatment. Moreover, growing demand for non-surgical alternatives for ocular diseases management further propels the overall market growth.
By Form:
By form is a part of ocular drug delivery and it's used to deliver drugs to the eye. There are two types of by-forms: non-invasive and invasive.
Application Insights:
Based on application, the global market is segmented into hospitals, ambulatory surgical centers, ophthalmic clinics and homecare settings. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as a high patient load and rising number of surgeries every year. In addition, an increase in the prevalence of chronic diseases such as diabetes mellitus and cancer may also contribute to this growth during the forecast period.
The homecare setting segment is anticipated to witness significant growth over the forecast period owing to increasing geriatric population across developed countries including Germany, Japan and France who require regular medical checkups at homes or local healthcare facilities for proper management of their health conditions related vision disorders.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high adoption rate for advanced ocular drug delivery systems, and favorable reimbursement policies pertaining to new or improved devices and drugs. The U.S., which is at the forefront of this region, accounted for more than 80% share in North America owing to its well-developed healthcare infrastructure along with an increasing geriatric population base suffering from age-related ophthalmic disorders such as macular degeneration (AMD).
Asia Pacific is expected to register lucrative growth over the forecast period due to factors such as improving healthcare facilities & infrastructure; rising prevalence/ incidence rates of eye diseases; growing target patient population base suffering from AMD and other retinal diseases; increase in per capita income leading towards overall improvement in quality of life & disposable income especially among middle class families who are now able afford private hospitalization & outpatient care services thereby driving demand for these products across this region.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The increasing prevalence of various eye diseases and disorders is one of the key growth drivers for the ocular drug delivery market. According to a study by the World Health Organization (WHO), over 285 million people are affected by visual impairment, which is expected to increase to more than 350 million by 2020. This growing population base is likely to create significant demand for ocular drug delivery products in the coming years.
- Rising awareness about eye health: There has been a rising awareness about eye health in recent years, owing to which patients are increasingly seeking treatment for various vision-related problems at an early stage. This is another major factor that is expected to drive growth of the ocular drug delivery market in the near future.
- Technological advancements: The advent of novel technologies such as nanotechnology and micro-injection systems has led to significant advancements in ocular drug delivery products and devices over the past few years, thereby propelling market growth further. These technological advances are likely to continue in forthcoming years as well, thus providing impetus to market expansion during this period too..
Scope Of The Report
Report Attributes
Report Details
Report Title
Ocular Drug Delivery Market Research Report
By Type
By Technology, By Form
By Application
Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, Homecare Settings
By Companies
OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc, Taiwan Liposome Company, Santen Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Ocular Drug Delivery Market Report Segments:
The global Ocular Drug Delivery market is segmented on the basis of:
Types
By Technology, By Form
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, Homecare Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- OCULAR THERAPEUTIX, INC
- Alimera Sciences
- Allergan, Plc
- EyeGate Pharma
- Valeant Pharmaceuticals International, Inc
- Envisia Therapeutics
- Clearside Biomedical
- Graybug Vision Inc
- Taiwan Liposome Company
- Santen Pharmaceutical
Highlights of The Ocular Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- By Technology
- By Form
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Ophthalmic Clinics
- Homecare Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ocular Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ocular drug delivery is a method of delivering medications to the eye. It can be done through drops, ointments, or patches that are placed on the eyes.
Some of the major players in the ocular drug delivery market are OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc, Taiwan Liposome Company, Santen Pharmaceutical.
The ocular drug delivery market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ocular Drug Delivery Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ocular Drug Delivery Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ocular Drug Delivery Market - Supply Chain
4.5. Global Ocular Drug Delivery Market Forecast
4.5.1. Ocular Drug Delivery Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ocular Drug Delivery Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ocular Drug Delivery Market Absolute $ Opportunity
5. Global Ocular Drug Delivery Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ocular Drug Delivery Market Size and Volume Forecast by Type
5.3.1. By Technology
5.3.2. By Form
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ocular Drug Delivery Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ocular Drug Delivery Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Ophthalmic Clinics
6.3.4. Homecare Settings
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ocular Drug Delivery Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ocular Drug Delivery Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ocular Drug Delivery Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ocular Drug Delivery Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ocular Drug Delivery Demand Share Forecast, 2019-2026
9. North America Ocular Drug Delivery Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ocular Drug Delivery Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ocular Drug Delivery Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Ophthalmic Clinics
9.4.4. Homecare Settings
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ocular Drug Delivery Market Size and Volume Forecast by Type
9.7.1. By Technology
9.7.2. By Form
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ocular Drug Delivery Demand Share Forecast, 2019-2026
10. Latin America Ocular Drug Delivery Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ocular Drug Delivery Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ocular Drug Delivery Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Ophthalmic Clinics
10.4.4. Homecare Settings
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ocular Drug Delivery Market Size and Volume Forecast by Type
10.7.1. By Technology
10.7.2. By Form
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ocular Drug Delivery Demand Share Forecast, 2019-2026
11. Europe Ocular Drug Delivery Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ocular Drug Delivery Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ocular Drug Delivery Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Ophthalmic Clinics
11.4.4. Homecare Settings
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ocular Drug Delivery Market Size and Volume Forecast by Type
11.7.1. By Technology
11.7.2. By Form
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ocular Drug Delivery Demand Share, 2019-2026
12. Asia Pacific Ocular Drug Delivery Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ocular Drug Delivery Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ocular Drug Delivery Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Ophthalmic Clinics
12.4.4. Homecare Settings
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ocular Drug Delivery Market Size and Volume Forecast by Type
12.7.1. By Technology
12.7.2. By Form
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ocular Drug Delivery Demand Share, 2019-2026
13. Middle East & Africa Ocular Drug Delivery Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ocular Drug Delivery Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ocular Drug Delivery Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Ophthalmic Clinics
13.4.4. Homecare Settings
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ocular Drug Delivery Market Size and Volume Forecast by Type
13.7.1. By Technology
13.7.2. By Form
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ocular Drug Delivery Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ocular Drug Delivery Market: Market Share Analysis
14.2. Ocular Drug Delivery Distributors and Customers
14.3. Ocular Drug Delivery Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. OCULAR THERAPEUTIX, INC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alimera Sciences
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Allergan, Plc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. EyeGate Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Valeant Pharmaceuticals International, Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Envisia Therapeutics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Clearside Biomedical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Graybug Vision Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Taiwan Liposome Company
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Santen Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
